Clinical trial
The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria
NCT00214851 · Nova Scotia Health Authority, Other · Completed
Key facts
| NCT number | NCT00214851 |
|---|---|
| Title | The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria |
| Official title | The Use of Kineret (Anakinra) in the Treatment of Familial Cold Urticaria |
| Lead sponsor | Nova Scotia Health Authority, Other |
| Collaborators | Atlantic Provinces Dermatology Association |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Familial Cold Urticaria |
| Intervention type | Drug |
| Interventions | Kineret (anakinra) |
| Enrollment | 8 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Sep 22, 2005 |
| Last update posted | Nov 8, 2022 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: